Find a Clinical Trial
Filter
Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus
Cutaneous disorders
All genders
18+
Recruiting now
Department of Dermatology
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
Psoriasis
Psoriasis
All genders
18+
Recruiting now
Department of Dermatology
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Assist
Chronic kidney disease
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology
VX19-NEN-801
Chronic kidney disease, Glomerular disease, Kidney diseases, Proteinuria
All genders
12-65
Recruiting now
Department of Medicine, Division of Nephrology
AMPLITUDE
Chronic kidney disease, Nephropathy, Proteinuria
All genders
18-65
Recruiting now
Department of Medicine, Division of Nephrology
CKD Registry
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology